“kite-pharma” Archives

in
Entry Author Date Location
Gilead Gets Another CAR-T Approval, This Time for Mantle Cell Lymphoma 07/24/20 San Francisco
Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact 05/27/20 San Francisco
Encouraging Signals for New Cancer Cell Therapy Strategies 05/06/20 National
Gilead Boosts Cancer Drug Pipeline With $4.9B Deal for Forty Seven 03/02/20 San Francisco
Gilead Ups Stake in Galapagos With $5B Deal to Jumpstart Its R&D 07/15/19 San Francisco
Merck And The Future of Immuno-Oncology: A Chat With Roger Perlmutter 01/16/19 National
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
Gilead Sciences Commits $150M to Agenus in Cancer Drug R&D Pact 12/20/18 San Francisco
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
Roche Vet O’Day Tapped to Shape Gilead’s Future as Hep C Sales Fall 12/10/18 San Francisco
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More 11/26/18 National
Allogene, Cortexyme & RDMD Headline Xconomy’s Dec. 5 Biotech Forum 11/08/18 San Francisco
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango 10/31/18 San Francisco
Allogene’s IPO Raises $288M for Tests of “Off-the-Shelf” Cell Therapy 10/11/18 San Francisco
Xconomy’s San Francisco Event to Showcase Biotech’s Next Generation 09/13/18 San Francisco
SQZ Biotech Adds $72M as Cell Therapy Investment Keeps Burning Hot 08/08/18 Boston
Bio Roundup: Lung Cancer Showdown, Gene Therapy Deals, IPO Busts 04/13/18 National
Bio Roundup: Ex-Kiters Say Allo, NASH Cash & Data, Alkermes No & More 04/06/18 National
Continuing Cell Therapy Push, Gilead Aligns with Sangamo for CAR-T Boost 02/22/18 San Francisco
Bio Roundup: Tax Cuts, Drug Approval Record, New Flagship Cash & More 12/22/17 National
ASH 2017 Highlights: CAR-T Competition, Myeloma, Hemophilia & More 12/11/17 National
Gilead Bets on Cell Therapy Again with $567M Cell Design Labs Deal 12/07/17 San Francisco
Gilman’s Next CEO Trick: Taming CAR-T Cells With Obsidian 12/06/17 Boston
Juno Dissects ROCKET Deaths, Will Aim Better CAR-T at Leukemia 11/10/17 Seattle
FDA Lifts Hold on Cellectis’s “Off the Shelf” CAR-T, With Caveats 11/07/17 New York
ASH Sneak Peeks: Novartis, Juno Update CAR-T Lymphoma Competition 11/01/17 National
Bio Roundup: Kite’s CAR-T Approved, Obamacare Fix & Lilly mRNA Deal 10/20/17 National
Kite Nabs First Adult CAR-T Approval With Notable Uptick Of Cures 10/18/17 National
Patient Death Triggers FDA Hold For Cellectis’s “Off the Shelf” CAR-T 09/05/17 New York
Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More 09/01/17 National
Page 1 of 4 next page »